<DOC>
	<DOCNO>NCT01965730</DOCNO>
	<brief_summary>This study hop determine optimal antifibrinolytic dosing decrease bleed blood transfusion cardiac surgery without increase adverse event</brief_summary>
	<brief_title>Dosing Amicar Measure Fibrinolysis TEG During Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Aortic Diseases</mesh_term>
	<mesh_term>Aminocaproic Acid</mesh_term>
	<criteria>Ability sign inform consent Elective cardiac surgery patient undergo primary surgery involve circulatory arrest Inability sign inform consent Baseline hypercoagulable condition define medical record Coronary disease untreated lesion recent coronary stent placement Severe renal dysfunction ( ESRD ) document medical record</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>dilate ascend aorta</keyword>
</DOC>